Skip to main content
Erschienen in: Lung 5/2016

09.05.2016

Evaluation of Simvastatin and Bone Marrow-Derived Mesenchymal Stem Cell Combination Therapy on Airway Remodeling in a Mouse Asthma Model

verfasst von: Maryam Mohammadian, Hamid Reza Sadeghipour, Iraj Ragerdi Kashani, Gila Pirzad Jahromi, Amene Omidi, Amir Kavian Nejad, Ravie Golchoobian, Mohammad Hossein Boskabady

Erschienen in: Lung | Ausgabe 5/2016

Einloggen, um Zugang zu erhalten

Abstract

Introduction

The effect of bone marrow-derived mesenchymal stem cells (BMSCs) on asthma treatment was shown in our previous study. Several studies have shown the effect of statins on BMSC preservation and migration to sites of inflammation. In this study, the effects of simvastatin and BMSC combination therapy in an ovalbumin-induced asthma model in mouse were examined.

Methods

Four groups of BALB/c mice were studied including control group (animals were not sensitized), asthma group (animals were sensitized by ovalbumin), asthma + simvastatin group (asthmatic animals were treated with simvastatin), and asthma + BMSC + simvastatin group (asthmatic animals were treated with simvastatin and BMSCs). BMSCs were isolated, characterized, labeled with BrdU, and transferred into asthmatic mice. BMSC migration, airways histopathology, and total and differential white blood cell (WBC) count in bronchoalveolar lavage (BAL) fluid were evaluated.

Results

A significant increase in the number of BrdU-BMSCs was found in the lungs of mice treated with simvastatin + BMSCs compared to mice treated with BMSCs. The histopathological changes, BAL total WBC counts, and the percentage of neutrophils and eosinophils were increased in asthma group compared to the control group. Treatment with simvastatin significantly decreased airway inflammation and inflammatory cell infiltration. Combination therapy improved all measured parameters higher than simvastatin. Goblet cell hyperplasia and subepithelial fibrosis were also decreased in combination therapy group.

Conclusion

These results indicated that simvastatin and BMSC combination therapy was superior to simvastatin therapy and BMSC therapy alone in reduction of airway remodeling and lung inflammation in the ovalbumin-induced asthma model in mouse.
Literatur
1.
Zurück zum Zitat Nakagome K, Nagata M (2011) Pathogenesis of airway inflammation in bronchial asthma. Auris Nasus Larynx 38:555–563CrossRefPubMed Nakagome K, Nagata M (2011) Pathogenesis of airway inflammation in bronchial asthma. Auris Nasus Larynx 38:555–563CrossRefPubMed
2.
Zurück zum Zitat Bloemen K, Verstraelen S, Van Den Heuvel R et al (2007) The allergic cascade: review of the most important molecules in the asthmatic lung. Immunol Lett 113:6–18CrossRefPubMed Bloemen K, Verstraelen S, Van Den Heuvel R et al (2007) The allergic cascade: review of the most important molecules in the asthmatic lung. Immunol Lett 113:6–18CrossRefPubMed
3.
Zurück zum Zitat Al-Muhsen S, Johnson JR, Hamid Q (2011) Remodeling in asthma. J Allergy Clin Immunol. 128:451–462CrossRefPubMed Al-Muhsen S, Johnson JR, Hamid Q (2011) Remodeling in asthma. J Allergy Clin Immunol. 128:451–462CrossRefPubMed
5.
Zurück zum Zitat Bonfield TL, Caplan AI (2010) Adult mesenchymal stem cells: an innovative therapeutic for lung diseases. Discov Med 9:337–345PubMed Bonfield TL, Caplan AI (2010) Adult mesenchymal stem cells: an innovative therapeutic for lung diseases. Discov Med 9:337–345PubMed
6.
Zurück zum Zitat Mohammadian M, Boskabady MH, Ragerdi Kashani IR et al (2015) Effect of bone marrow derived mesenchymal stem cells on lung pathology and inflammation in ovalbumin- induced asthma in mouse. Iran J Basic Med Sc. 19:55–63 Mohammadian M, Boskabady MH, Ragerdi Kashani IR et al (2015) Effect of bone marrow derived mesenchymal stem cells on lung pathology and inflammation in ovalbumin- induced asthma in mouse. Iran J Basic Med Sc. 19:55–63
7.
Zurück zum Zitat Boskabady MH, Keyhanmanesh R, Khamneh S et al (2011) Potential immunomodulation effect of Nigella sativa on ovalbumin sensitized guinea pigs. J Zhejiang Univ Sci B 12:201–209CrossRefPubMedPubMedCentral Boskabady MH, Keyhanmanesh R, Khamneh S et al (2011) Potential immunomodulation effect of Nigella sativa on ovalbumin sensitized guinea pigs. J Zhejiang Univ Sci B 12:201–209CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Boskabady MH, Shahmohammadi Mehrjardi S, Rezaee A et al (2013) The impact of Zataria multiflora Boiss extract on in vitro and in vivo Th1/Th2 cytokine (IFN-γ/IL4) balance. J Ethnopharmacpol 150:1024–1031CrossRef Boskabady MH, Shahmohammadi Mehrjardi S, Rezaee A et al (2013) The impact of Zataria multiflora Boiss extract on in vitro and in vivo Th1/Th2 cytokine (IFN-γ/IL4) balance. J Ethnopharmacpol 150:1024–1031CrossRef
9.
Zurück zum Zitat Bayrami G, Boskabady MH, Jalali S et al (2013) The effect of the extract of Crocus sativus on tracheal responsiveness and plasma levels of IL-4, IFN-γ, total NO and nitrite in ovalbumin sensitized Guinea-pigs. J Ethnopharmacol 147:530–535CrossRef Bayrami G, Boskabady MH, Jalali S et al (2013) The effect of the extract of Crocus sativus on tracheal responsiveness and plasma levels of IL-4, IFN-γ, total NO and nitrite in ovalbumin sensitized Guinea-pigs. J Ethnopharmacol 147:530–535CrossRef
10.
Zurück zum Zitat Mahmood A, Lu D, Lu M et al (2003) Treatment of traumatic brain injury in adult rats with intravenous administration of human bone marrow stromal cells. Neurosurgery 53:697–702CrossRefPubMed Mahmood A, Lu D, Lu M et al (2003) Treatment of traumatic brain injury in adult rats with intravenous administration of human bone marrow stromal cells. Neurosurgery 53:697–702CrossRefPubMed
11.
Zurück zum Zitat Muller-Ehmsen J, Krausgrill B, Burst V et al (2006) Effective engraftment but poor mid-term persistence of mononuclear and mesenchymal bone marrow cells in acute and chronic rat myocardial infarction. J Mol Cell Cardiol 41:876–884CrossRefPubMed Muller-Ehmsen J, Krausgrill B, Burst V et al (2006) Effective engraftment but poor mid-term persistence of mononuclear and mesenchymal bone marrow cells in acute and chronic rat myocardial infarction. J Mol Cell Cardiol 41:876–884CrossRefPubMed
12.
Zurück zum Zitat Borlongan CV, Lind JG, Dillon-Carter O et al (2004) Bone marrow grafts restore cerebral blood flow and blood brain barrier in stroke rats. Brain Res 1010:108–116CrossRefPubMed Borlongan CV, Lind JG, Dillon-Carter O et al (2004) Bone marrow grafts restore cerebral blood flow and blood brain barrier in stroke rats. Brain Res 1010:108–116CrossRefPubMed
13.
Zurück zum Zitat Zhang Q, Yang YJ, Wang H et al (2012) Autophagy activation: a novel mechanism of atorvastatin to protect mesenchymal stem cells from hypoxia and serum deprivation via AMP-activated protein kinase/mammalian target of rapamycin pathway. Stem Cells Dev 21:1321–1332CrossRefPubMedPubMedCentral Zhang Q, Yang YJ, Wang H et al (2012) Autophagy activation: a novel mechanism of atorvastatin to protect mesenchymal stem cells from hypoxia and serum deprivation via AMP-activated protein kinase/mammalian target of rapamycin pathway. Stem Cells Dev 21:1321–1332CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Zhang Y, Zhang R, Li Y et al (2012) Simvastatin augments the efficacy of therapeutic angiogenesis induced by bone marrow-derived mesenchymal stem cells in a murine model of hindlimb ischemia. Mol Biol Rep 39:285–293CrossRefPubMed Zhang Y, Zhang R, Li Y et al (2012) Simvastatin augments the efficacy of therapeutic angiogenesis induced by bone marrow-derived mesenchymal stem cells in a murine model of hindlimb ischemia. Mol Biol Rep 39:285–293CrossRefPubMed
15.
Zurück zum Zitat Cui X, Chopp M, Zacharek A et al (2009) Chemokine, vascular and therapeutic effects of combination Simvastatin and BMSC treatment of stroke. Neurobiol Dis 36:35–41CrossRefPubMedPubMedCentral Cui X, Chopp M, Zacharek A et al (2009) Chemokine, vascular and therapeutic effects of combination Simvastatin and BMSC treatment of stroke. Neurobiol Dis 36:35–41CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Ou XM, Wen FQ, Uhal BD et al (2009) Simvastatin attenuates experimental small airway remodelling in rats. Respirology 14:734–745CrossRefPubMed Ou XM, Wen FQ, Uhal BD et al (2009) Simvastatin attenuates experimental small airway remodelling in rats. Respirology 14:734–745CrossRefPubMed
17.
Zurück zum Zitat Zeki AA, Franzi L, Last J et al (2009) Simvastatin inhibits airway hyperreactivity: implications for the mevalonate pathway and beyond. Am J Respir Crit Care Med 180:731–740CrossRefPubMedPubMedCentral Zeki AA, Franzi L, Last J et al (2009) Simvastatin inhibits airway hyperreactivity: implications for the mevalonate pathway and beyond. Am J Respir Crit Care Med 180:731–740CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Firinci F, Karaman M, Baran Y et al (2011) Mesenchymal stem cells ameliorate the histopathological changes in a murine model of chronic asthma. Int Immunopharmacol 11:1120–1126CrossRefPubMed Firinci F, Karaman M, Baran Y et al (2011) Mesenchymal stem cells ameliorate the histopathological changes in a murine model of chronic asthma. Int Immunopharmacol 11:1120–1126CrossRefPubMed
19.
Zurück zum Zitat Pirzad Jahromi G, Seidi S, Sadr SS et al (2012) Therapeutic effects of a combinatorial treatment of simvastatin and bone marrow stromal cells on experimental embolic stroke. Basic Clin Pharmacol Toxicol 110:487–493CrossRefPubMed Pirzad Jahromi G, Seidi S, Sadr SS et al (2012) Therapeutic effects of a combinatorial treatment of simvastatin and bone marrow stromal cells on experimental embolic stroke. Basic Clin Pharmacol Toxicol 110:487–493CrossRefPubMed
20.
21.
Zurück zum Zitat Song X, Xie S, Lu K et al (2015) Mesenchymal stem cells alleviate experimental asthma by inducing polarization of alveolar macrophages. Inflammation 38:485–492CrossRefPubMed Song X, Xie S, Lu K et al (2015) Mesenchymal stem cells alleviate experimental asthma by inducing polarization of alveolar macrophages. Inflammation 38:485–492CrossRefPubMed
22.
Zurück zum Zitat Zaminy A, Kashani IR, Barbarestani M et al (2008) Osteogenic differentiation of rat mesenchymal stem cells from adipose tissue in comparison with bone marrow mesenchymal stem cells: melatonin as a differentiation Factor. Iran Biomed J 12:133–141PubMed Zaminy A, Kashani IR, Barbarestani M et al (2008) Osteogenic differentiation of rat mesenchymal stem cells from adipose tissue in comparison with bone marrow mesenchymal stem cells: melatonin as a differentiation Factor. Iran Biomed J 12:133–141PubMed
23.
Zurück zum Zitat Pachón-Peña G, Yu G, Tucker A et al (2011) Stromal stem cells from adipose tissue and bone marrow of age-matched female donors display distinct immunophenotypic profiles. J Cell Physiol 226:843–851CrossRefPubMedPubMedCentral Pachón-Peña G, Yu G, Tucker A et al (2011) Stromal stem cells from adipose tissue and bone marrow of age-matched female donors display distinct immunophenotypic profiles. J Cell Physiol 226:843–851CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Qian C, Tio RA, Roks AJ et al (2007) A promising technique for transplantation of bone marrow-derived endothelial progenitor cells into rat heart. Cardiovasc Pathol. 16:127–135CrossRefPubMed Qian C, Tio RA, Roks AJ et al (2007) A promising technique for transplantation of bone marrow-derived endothelial progenitor cells into rat heart. Cardiovasc Pathol. 16:127–135CrossRefPubMed
25.
Zurück zum Zitat Khakzad MR, Mirsadraee M, Mohammadpour A et al (2012) Effect of verapamil on bronchial goblet cells of asthma: an experimental study on sensitized animals. Pulm Pharmacol Ther 25:163–168CrossRefPubMed Khakzad MR, Mirsadraee M, Mohammadpour A et al (2012) Effect of verapamil on bronchial goblet cells of asthma: an experimental study on sensitized animals. Pulm Pharmacol Ther 25:163–168CrossRefPubMed
26.
Zurück zum Zitat Cao R, Dong XW, Jiang JX et al (2011) M(3) muscarinic receptor antagonist bencycloquidium bromide attenuates allergic airway inflammation, hyperresponsiveness and remodeling in mice. Eur J Pharmacol 655:83–90CrossRefPubMed Cao R, Dong XW, Jiang JX et al (2011) M(3) muscarinic receptor antagonist bencycloquidium bromide attenuates allergic airway inflammation, hyperresponsiveness and remodeling in mice. Eur J Pharmacol 655:83–90CrossRefPubMed
27.
Zurück zum Zitat Ou-Yang HF, Huang Y, Hu XB et al (2011) Suppression of allergic airway inflammation in a mouse model of asthma by exogenous mesenchymal stem cells. Exp Biol Med 236:1461–1477CrossRef Ou-Yang HF, Huang Y, Hu XB et al (2011) Suppression of allergic airway inflammation in a mouse model of asthma by exogenous mesenchymal stem cells. Exp Biol Med 236:1461–1477CrossRef
28.
Zurück zum Zitat Cui X, Chopp M, Zacharek A et al (2009) Chemokine, vascular and therapeutic effects of combination Simvastatin and BMSC treatment of stroke. Neurobiol Dis 361:35–41CrossRef Cui X, Chopp M, Zacharek A et al (2009) Chemokine, vascular and therapeutic effects of combination Simvastatin and BMSC treatment of stroke. Neurobiol Dis 361:35–41CrossRef
29.
Zurück zum Zitat Neamati A, Boskabady MH, Mohaghegh Hazrati S, Khakzad MR, Moosavi SH (2013) The effect of natural adjuvants (G2, G2F) on lung inflammation of sensitized guinea pigs. Avicenna J Phytomed 3:364–370PubMedPubMedCentral Neamati A, Boskabady MH, Mohaghegh Hazrati S, Khakzad MR, Moosavi SH (2013) The effect of natural adjuvants (G2, G2F) on lung inflammation of sensitized guinea pigs. Avicenna J Phytomed 3:364–370PubMedPubMedCentral
30.
Zurück zum Zitat Bonfield TL, Koloze M, Lennon DP et al (2010) Human mesenchymal stem cells suppress chronic airway inflammation in the murine ovalbumin asthma model. Am J Physiol 299:760–770CrossRef Bonfield TL, Koloze M, Lennon DP et al (2010) Human mesenchymal stem cells suppress chronic airway inflammation in the murine ovalbumin asthma model. Am J Physiol 299:760–770CrossRef
31.
Zurück zum Zitat Xu L, Dong XW, Shen LL et al (2012) Simvastatin delivery via inhalation attenuates airway inflammation in a murine model of asthma. Int Immunopharmacol 12:556–564CrossRefPubMed Xu L, Dong XW, Shen LL et al (2012) Simvastatin delivery via inhalation attenuates airway inflammation in a murine model of asthma. Int Immunopharmacol 12:556–564CrossRefPubMed
32.
Zurück zum Zitat Kim DY, Ryu SY, Lim JE et al (2007) Anti-inflammatory mechanism of simvastatin in mouse allergic asthma model. Eur J Pharmacol 557:76–86CrossRefPubMed Kim DY, Ryu SY, Lim JE et al (2007) Anti-inflammatory mechanism of simvastatin in mouse allergic asthma model. Eur J Pharmacol 557:76–86CrossRefPubMed
33.
Zurück zum Zitat Kim SE, Thanh Thuy TT, Lee JH et al (2009) Simvastatin inhibits induction of matrix metalloproteinase-9 in rat alveolar macrophages exposed to cigarette smoke extract. Exp Mol Med 41:277–287CrossRefPubMedPubMedCentral Kim SE, Thanh Thuy TT, Lee JH et al (2009) Simvastatin inhibits induction of matrix metalloproteinase-9 in rat alveolar macrophages exposed to cigarette smoke extract. Exp Mol Med 41:277–287CrossRefPubMedPubMedCentral
34.
Zurück zum Zitat Braganza G, Chaudhuri R, McSharry C et al (2011) Effects of short-term treatment with atorvastatin in smokers with asthma–a randomized controlled trial. BMC Pulm Med 11:16CrossRefPubMedPubMedCentral Braganza G, Chaudhuri R, McSharry C et al (2011) Effects of short-term treatment with atorvastatin in smokers with asthma–a randomized controlled trial. BMC Pulm Med 11:16CrossRefPubMedPubMedCentral
Metadaten
Titel
Evaluation of Simvastatin and Bone Marrow-Derived Mesenchymal Stem Cell Combination Therapy on Airway Remodeling in a Mouse Asthma Model
verfasst von
Maryam Mohammadian
Hamid Reza Sadeghipour
Iraj Ragerdi Kashani
Gila Pirzad Jahromi
Amene Omidi
Amir Kavian Nejad
Ravie Golchoobian
Mohammad Hossein Boskabady
Publikationsdatum
09.05.2016
Verlag
Springer US
Erschienen in
Lung / Ausgabe 5/2016
Print ISSN: 0341-2040
Elektronische ISSN: 1432-1750
DOI
https://doi.org/10.1007/s00408-016-9884-1

Weitere Artikel der Ausgabe 5/2016

Lung 5/2016 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.